Table 12 Assessment of responsiveness of the EQ-5D-3L and the EQ-5D-5L measures to changes in the Barthel Index, for the subgroup in Belgium
EQ-5D-3L at 6 months (mean) | EQ-5D-3L at 12 months (mean) | Difference between 12 and 6 months EQ-5D-3L (95% CI) | Effect size (Cohen’s D)a | n | % reporting 3L score increase | |
|---|---|---|---|---|---|---|
Barthel Index | ||||||
Improved | 0.54 | 0.67 | 0.12 (− 0.21 to 0.45) | 0.34 | 5 | 40 |
No change | 0.84 | 0.84 | 0.00 (− 0.04 to 0.03) | 0.00 | 37 | 22 |
Worsened | 0.80 | 0.67 | − 0.13 (− 0.29 to 0.03) | − 0.65 | 15 | 20 |
EQ-5D-5L at 6 months (mean) | EQ-5D-5L at 12 months (mean) | Difference between 12 and 6 months EQ-5D-5L (95% CI) | Effect size (Cohen’s D) | n | % reporting 5L score increase | |
|---|---|---|---|---|---|---|
Barthel Index | ||||||
Improved | 0.63 | 0.64 | 0.01 (− 0.09 to 0.11) | 0.07 | 5 | 20 |
No change | 0.81 | 0.81 | 0.00 (− 0.03 to 0.03) | 0.00 | 37 | 38 |
Worsened | 0.75 | 0.63 | − 0.11 (− 0.24 to 0.01) | − 0.67 | 15 | 33 |